Evidence map›Paper›PMID 39493554›Full record

ArticleWorld journal of diabetes2024

Interleukin-35: A key player managing pre-diabetes and chronic inflammatory type 1 autoimmune diabetes.

Ratul Chakraborty, Ashis Kumar Mukherjee, Asis Bala

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Role of Interleukins in Type 1 and Type 2 Diabetes.Diagnostics (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ratul ChakrabortyLife Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati 781035, Guwahati, Assam, India.
Ashis Kumar MukherjeeLife Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati 781035, Guwahati, Assam, India.
Asis BalaPharmacology and Drug Discovery Research Laboratory, Division of Life Sciences, Institute of Advanced Study in Science and Technology, Guwahati 781035, Assam, India. asisbala@iasst.gov.in. asisbala@iasst.gov.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-35 (IL-35) is a novel protein comprising IL-12α and IL-27β chains. The IL12A and

Indexed as

Autoimmune diabetesChronic inflammatory type diabetesGene disease associationInterleukin-35Pancreatic inflammation

Identifiers

PMID39493554
PMCPMC11525726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.